- ￥500
- MedChemExpress(MCE)
- 中国
- HY-132136-100mg
- 2025年07月20日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
广州威佳科技有限公司
- CAS号：
109389-30-2
- 规格：
100mg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Synthesis of a 4‐Selenothymidine Phosphoramidite and Incorporation into Oligonucleotides
synthetic protocol for a 4?selenothymidine phosphoramidite and its use to prepare modified oligonucleotides is described here. The Se?phosphoramidite synthesis was achieved by developing a useful protection and deprotection system for the selenium
synthetic protocol for a 2?selenothymidine phosphoramidite and its use in preparing Se?derivatized oligonucleotides are described here. The Se?modified phosphoramidite synthesis was achieved by activating a 2?thiothymidine derivative, followed
Oligodeoxyribonucleotides Synthesis: Phosphoramidite Approach
The development of deoxyribonucleoside phosphoramidite derivatives for the synthesis of oligodeoxyribonucleotides was first described by Beaucage and Caruthers ( 1 ) in 1981. The conceptual basis of this methodology emerged as a modification
技术资料暂无技术资料 索取技术资料
